FemTech represents a trillion-dollar opportunity. So why do all-female teams receive just 2% of early-stage venture capital?
Beata Wandachowicz-Krason has spent years researching what is holding FemTech back — the funding gaps, the cultural taboos, and the structural misalignment between how healthcare systems are built and what women’s health actually requires.
In this episode, she breaks down why the relatability gap between female founders and male investors is one of the biggest blockers in the sector, and what founders can do about it right now.
You’ll hear why pitching FemTech as a social cause is the wrong move, how to pivot from risk-based investor questions back to growth, and why male allyship is not optional if the sector is going to scale.
What we cover:
The funding paradox: 85% female-led ventures, 2% of VC funding
Why 90% male VC decision-making creates a structural relatability problem
Cultural taboos around menopause, miscarriage, and chronic pain — and how they suppress both patient voices and founder credibility
How healthcare systems optimized for acute care create a prevention gap that FemTech is trying to fill
Why AI tools are censoring the very medical terms that took decades to legitimize
How to build a data-driven, economically aggressive pitch that moves FemTech out of the wellness niche
The pivot technique: answering risk-based questions without losing the growth narrative
Why male allyship — done right — accelerates the sector rather than co-opting it
Data privacy in women’s health: why the taboo is a bigger barrier than the technology
Practical tools for combating gender bias in the funding process
About Beata Wandachowicz-Krason Beata is an executive at Organon and a researcher focused on the systemic barriers holding FemTech back. She works at the intersection of women’s health, venture capital, and ecosystem building.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dirkjan Hupkes. Innehållet i podden är skapat av Dirkjan Hupkes och inte av,
eller tillsammans med, Poddtoppen.